The Babraham Institute, a biotech research unit of Cambridge University, has announced the creation of a new commercialisation vehicle backed by a £44m ($67m) government grant. Babraham Commercialisation Services (BCS) will support the knowledge exchange and commercialisation activities of the institute, already home to around 45 biomedical companies at its research campus. The campus is…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
